SCHEMBL20920576

SCHEMBL20920576

COc1ccccc1-c1ccnc(N2CCOCC2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.63
▸ MAPT P10636 3/20 0.63
▸ LMNA P02545 2/20 0.63
▸ L3MBTL1 Q9Y468 2/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ ALOX15 P16050 1/20 0.63
▸ TSHR P16473 1/20 0.63
▸ KMT2A Q03164 1/20 0.63
▸ AGER Q15109 1/20 0.63
▸ HSD17B10 Q99714 1/20 0.63
▸ TDP1 Q9NUW8 1/20 0.63
▸ MTOR P42345 5/20 0.60
▸ CNR2 P34972 1/20 0.58
▸ CCNT1 O60563 2/20 0.53
▸ CDK9 P50750 2/20 0.53
▸ CCNA2 P20248 1/20 0.53
▸ CDK2 P24941 1/20 0.53
▸ EIF2AK2 P19525 1/20 0.52
▸ PIK3CA P42336 2/20 0.51
▸ PIK3CD O00329 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11927962 0.86 MTOR (0.65) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL26985639 0.85 HTR7 (0.56) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL31505935 0.85 HTR7 (0.56) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL13555486 0.80 CCNT1 (0.56) KDM4EMAPTTSHRMTORCCNT1
SCHEMBL23365176 0.80 CYP3A4 (0.70) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL29914354 0.80 CYP3A4 (0.70) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL27556785 0.79 LMNA (0.53) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL16603970 0.77 KDM4E (1.00) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL16607164 0.77 KDM4E (0.69) KDM4EMAPTLMNAL3MBTL1MEN1
SCHEMBL27649921 0.77 KDM4E (0.66) KDM4EMAPTLMNAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-08-04 — — US disclosed
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2019-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof AGER, IAPP, GPR119 KDM4E 3803/4885MAPT 1914/4885LMNA 1219/4885
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof AGER, IAPP, GPR119 KDM4E 3803/4885MAPT 1914/4885LMNA 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback